Identification of long and short RNAs, their processing and expression patterns have been greatly facilitated by highthroughput sequencing. Frequently, these RNAs act as guides for ribonucleoprotein complexes that regulate the expression or processing of target RNAs. However, to determine the targets of the many newly discovered regulatory RNAs in highthroughput remains a challenge. To globally assign guide small nucleolar RNAs to site of 2'Oribose methylation in human cells, we here developed novel computational methods for the analysis of data that was generated with protocols designed to capture direct small RNAtarget interactions and to identify the sites of 2'Oribose methylation genomewide. We thereby determined that many "orphan" snoRNAs appear to guide 2'Oribose methylation at sites that are targeted by other snoRNAs and that snoRNAs can be reliably captured in interaction with many mRNAs, in which a subsequent 2'Omethylation cannot be detected. Our study provides a reliable approach to the comprehensive characterization of snoRNAtarget interactions in species beyond those in which these interactions have been traditionally studied and contribute to the rapidly developing field of "epitranscriptomics".
INTRODUCTION
RNAs undergo many different modifications in all living organisms (1) . Highthroughput approaches have been developed recently to map genomewide 2'Oribose methylation (2'OMe, (2) ) and the most frequent modified nucleobases including N6methyladenosine (m6A, (3) ), pseudouridine (ψ, (4) ), and 5methylcytosine (m5C, (5) ). These studies have catalyzed the birth of "epitranscriptomics" (6) and have rekindled the interest in the function of RNA modifications and their relevance for human diseases (7, 8) . Whereas 2'Oribose methylation has long been implicated in the stability and structure of ribosomal RNAs (reviewed in (9) ) and m6A appears to modulate the rate of mRNA translation (10) (11) (12) (13) , the role of most RNA modifications remains to be characterized. The 2'Omethylation of riboses in rRNAs and some other noncoding RNAs such as snRNAs and tRNAs (14, 15) is catalyzed by the protein fibrillarin (16) , which is part of a ribonucleoprotein complex additionally containing the 15.5K, NOP56 and NOP58 proteins. The complex is guided to targets by C/Dbox small nucleolar RNAs (snoRNA), which take their name from the conserved sequence elements that they contain, known as C/C' (RUGAUGA, R = A or G) and D/D' (CUGA) boxes. These are important for snoRNA biogenesis and for interaction with RNA binding proteins (17) . A snoRNA interacts with its targets through "antisense" elements that are located upstream of the D and/or D' box. The target nucleotide that pairs with the fifth nucleotide of the snoRNA antisense sequence acquires the 2'Oribosemethylation mark. Many studies have investigated snoRNAguided modifications, particularly in yeast (18) (19) (20) (21) . As a result, some features characterizing functional snoRNAtarget site interactions have been inferred and are used in the computational prediction of snoRNA targets (22, 23) . For instance, validated snoRNAtarget interactions indicate that the 3' end of the antisense box should be highly complementary to the target site, with no more than one mismatch over at least 7 nucleotides and no bulges (23) .
Until recently, experimental methods for snoRNA target site identification were laborious and could only address a few sites at a time (24) . This has changed with the development of an increased throughput method, CLASH (crosslinking, ligation and sequencing of hybrids), which enables isolation of RNARNA hybrids that form between snoRNAs and their targets (25) . The approach has also been applied to the identification of microRNA targets (26) . Although CLASH has limited efficiency of target capture (27) compared to crosslinking and immunoprecipitation of protein components of ribonucleoprotein complexes (CLIP) (28, 29) , it has the advantage that it reveals not only the target site but also the identity of the guide RNA. Interestingly, a recent study found that a small fraction of reads obtained in CLIP experiments represents RNAtarget chimeras, which are thought to form due to cellular enzymes ligating the guide miRNA to its target RNA during CLIP (30) . Whether the CLIP of core snoRNPs also yields snoRNAtarget chimeras has not been investigated.
In parallel to the high throughput capture of snoRNA targets, efforts were undertaken to map all 2'Omethylated riboses in ribosomal RNAs (2) . The novel RiboMethseq method takes advantage of the resistance of 2'Omethylated riboses to alkaline hydrolysis and led to the mapping of 54 annotated and 1 predicted 2'Omethylated site in S. cerevisiae .
Studies from various groups including ours have recently expanded the set of human snoRNAs, beyond those that are cataloged in snoRNAbase ( https://wwwsnorna.biotoul.fr/ (31) ) (32) (33) (34) . Analyzing the small RNA sequencing data sets generated by the ENCODE consortium and taking advantage of the processing pattern that most C/Dbox snoRNAs seem to follow (33) , we have recently constructed an updated catalog of human snoRNAs (Supplementary Table 1 , Jorjani et al. submitted) . Many of these molecules identified in small RNA sequencing data as well as snoRNP protein CLIP experiments, contain only a subset of C/D box snoRNAspecific sequence elements and with few exceptions, they lack predicted targets. They are therefore being referred to as snoRNAlike (33) . In our previous study (Jorjani et al. submitted) we also found that many snoRNAs are differentially expressed, not only between tissues but also in cancers. This finding suggests that snoRNAguided 2'Oribose methylation plays a role in human diseases.
In the present study we have combined recently published highthroughput experimental protocols with novel computational analysis methods to globally assign guide snoRNAs to 2'OMe sites in human cells. We first sought to identify chimeric sequences, composed of a snoRNA and a corresponding target, among the reads obtained by crosslinking and immunoprecipitation (CLIP) of core snoRNPs. To validate the role of CLIPbased identified interactions in 2'Omethylation we then applied RiboMethseq (2) . Intersecting highconfidence site sets obtained with the two methods, we have recovered~70% of the previously annotated 2'OMe sites in human rRNAs. We additionally assigned SNORD30 as guide for the modification at position 1383 of rRNA18S and we found that SNORD2 guides a previously unknown 2'OMe modification at position G2435 of rRNA28S. Because the CLIPbased capture of chimeric, guide RNAtarget, reads has low efficiency ( (30) and our results below), we have also sought supportive evidence for highconfidence 2'OMe sites determined with RiboMethseq among the lowprobability sites inferred from chimeric reads. Additionally, we used the data generated with another protocol that we previously developed to identify modification sites (RiMseq, see Jorjani et al. submitted). This approach yielded 5 novel sites in rRNAs, two of which were supported also by the RiMseq data. Some interactions with strong chimeric read support, particularly outside of the canonical snoRNA targets, do not seem to lead to 2'Oribose methylation that can be detected with RiboMethseq or RiMseq. This may indicate that C/D box snoRNA interaction with target sites have functions beyond the 2'Oribose methylation. Interestingly, these interactions seem to be guided by neurally expressed snoRNAs and involve genes that are associated with neuronal dysfunctions.
MATERIALS AND METHODS

CLIP of snoRNP core proteins
To identify chimeric snoRNAtarget reads, we analyzed 5 CLIP data sets that were published before (33) : 2 NOP58CLIP (Gene Expression Omnibus accession numbers GSM1067861 and GSM1067862), 1 NOP56CLIP (GEO accession GSM1067863) and 2 FBLCLIP (GEO accession GSM1067864 and GSM1067865). We also generated an additional FBLCLIP data set with the protocol described in (35) (GEO accession # pending).
Identification of snoRNAtarget chimera
SnoRNA and target sets
We obtained the most comprehensive annotation of human snoRNA sequences, genome coordinates and known or predicted targets from the human snoRNA atlas generated by (Jorjani et al. submitted) . RNAs that are known targets of snoRNAs (rRNA and snRNA) were downloaded from the snoRNA database (31) . tRNA sequences were obtained from GtRNAdb (36) , and one tRNA sequence per codon was added to the set of putative snoRNA targets. The target database thus consisted of the hg19 version of the human genome assembly, enhanced with rRNA, snRNA and tRNA sequences.
Computational analysis of chimeric reads
Analogous to a study that mapped miRNAtarget interactions based on chimeric reads (30) , we developed a method applicable to snoRNAs as follows.
Read selection
We carried out an initial annotation of CLIP data sets with the CLIPZ web server (37) , which provides as output genomemapped reads with their respective annotations, as well as the unmapped reads. We used clusters of overlapping mapped reads to extract putative target sites and the unmapped reads longer than 24 nucleotides to search for snoRNAtarget chimeras.
Detection of snoRNAs fragments in unmapped reads
From each snoRNA we generated all possible subsequences of 12 nucleotides in length ("anchors"). When an anchor was found in a chimeric read, we aligned the corresponding snoRNA to the chimeric read with a local alignment algorithm (SmithWaterman, implemented by swalign python package ( https://pypi.python.org/pypi/swalign ) with parameters: match = 2, mismatch penalty = 5, gap open penalty = 6, gap extension penalty = 4). For each chimeric read we retained only the snoRNA(s) with the best local alignment score. Only~20% of the initially unmapped reads in our dataset had such ambiguities. To evaluate the significance of the alignment scores, we applied the same procedure to shuffled reads. As shown in Supplementary Figure 1 , for most of the reads the score of the alignment with the snoRNA presumed to be contained in the read was much higher compared to the score of aligning the snoRNA to a shuffled version of the read. Thus, as it appears that some unmapped reads indeed include a snoRNA fragment, we analyzed them further as follows. We called the part of a chimeric read that could be aligned to a snoRNA the "snoRNA fragment" and the rest of the read "putative target fragment". All reads with a putative target fragment of at least 15 nucleotides were considered candidate chimeras which we analyzed further as described below.
Annotation of putative target fragments extracted from chimeric reads
Putative target fragments were mapped to CLIPed sites (defined as clusters of at least 2 genomemapped reads) as well as to rRNA, snRNA and tRNA sequences, which are known to be subject of snoRNAguided modification. Because the PARCLIP protocol yields reads in which C nucleotides are incorporated at the sites of crosslinked U's, we generated singlepoint variant of the reads, with one C nucleotide changed to a U before carrying out the mapping of the putative target fragments (30) with Bowtie2 in the local alignment mode. Command line parameters were as follows: f D100 L 13 i C,1 scoremin C,30 local k 10. For reads that mapped to multiple genomic loci, we checked whether at least one of these loci corresponded to a canonical snoRNA target, rRNA or snRNA. If so, we kept only the canonical locus. Otherwise, we kept all putative target loci. The statistics for each experiment can be viewed in Supplementary Table 2 .
Training a model of snoRNAtarget interaction
To develop a model that can distinguish bona fide snoRNAtarget interactions captured in chimeras from erroneously processed reads, we identified putative targets sites that were captured in multiple chimeras with the same snoRNA and had a PLEXYpredicted energy of interaction (22) lower than 12 kcal/mol. In the combined CLIP experiments we identified 67 unique sites known to undergo 2'Oribose methylation and 295 sites where a modification is not so far known to occur in the 28S and 18S ribosomal rRNAs.
For each site we calculated the features described below and trained a model to predict modification sites in the 28S rRNA. We evaluated the performance of the model using the the known modification sites on the 18S rRNA as true positives and all other sites in the 18S rRNA as true negatives. As the performance was high, we combined the two data sets and retrained a model for the comprehensive identification of snoRNAtarget interactions.
Feature definition and computation Interaction energy (PLEXY)
PLEXY is a tool for computational prediction of C/D box snoRNA targets genomewide, which uses nearestneighbor energy parameters to compute thermodynamically stable C/Dbox snoRNA target RNA interactions (22, 38) and further applies a set of rules to filter out likely false positives. For each putative target fragment that mapped to the database of putative targets (see section SnoRNA and target sets) we extracted a 50 nucleotides long sequence centered on the target part of the chimeric read, and calculated its interaction energy with the snoRNA in the chimeric read. PLEXY also assigns the position of the snoRNAinduced modification and we kept this information for further analyses. As control, we shuffled the snoRNA associated with each target part in a chimeric reads and repeated the calculation.
Target site accessibility
We defined the accessibility of the target region as the probability that a 21 ntslong anchored at the 5' end at the 7nts long minimal snoRNA interaction site is in single stranded conformation within an extended region of 30 nucleotides upstream and 30 nucleotides downstream of the minimal interaction site. We computed this parameter with CONTRAfold (39) .
Nucleotide content of flanking regions
We defined the 'Flanks A content' as the proportion of adenines within 30 nt upstream and 30 nt downstream of the 5'anchored minimal 7nucleotide long target region predicted to interact with the antisense box of the snoRNA. We similarly computed the frequencies of the other nucleotides. Because the frequency of adenines was most predictive of positive interaction sites (Supplementary Figure 2) we only used this feature in the model.
Model training
The histograms constructed separately for the positive and negative sites in the 28S and 18S rRNAs indicated clear differences between positive and negative sites in the features described above ( Figure 1 ). We used the Statsmodels python library (40) to train a generalized linear model (GLM) with the logit link function (logistic regression). For the comprehensive analysis of the chimeric read data, we used a model which we built based on all rRNA18S and rRNA28S sites (Supplementary Table 3 ).
Annotation of modification sites
We annotated the modification sites based on the ENSEMBL version 75 (41) and the RMSK table from University of California Santa Cruz genome browser (42) , for the repeat elements.
RiboMethseq Preparation and sequencing of RiboMethseq libraries
To globally map 2'OMe sites we adapted the recently developed RiboMethseq highthroughput experimental method (2) and applied it to mammalian cells. The principle of the method is that nucleotides with a 2'OMe ribose are resistant to alkaline hydrolysis. Thus, products of partial alkaline hydrolysis should not start or end at 2'OMe sites, leading to an underrepresentation of these positions among read starts/ends. The read starts/ends will thus provide a negative image of the methylation landscape (2) . We applied RiboMethseq to map 2'OMe sites in rRNA and poly(A)enriched RNA obtained from either the nucleus or cytoplasmic fraction of HEK293 cells. We also carried out the alkaline hydrolysis for different time intervals of 8, 14 or 20 minutes. The samples that we prepared were as follows:
RiboMethSeq_HEK_totalRNA_8min
RiboMethSeq_HEK_totalRNA_14min RiboMethSeq_HEK_totalRNA_20min RiboMethSeq_HEK_polyARNA_8min RibomethSeq_HEK_cytoplasmic1_14min RibomethSeq_HEK_cytoplasmic2_14min RibomethSeq_HEK_nuclear1_14min
RibomethSeq_HEK_nuclear2_14min
Total RNA was extracted with TRI Reagent (Sigma) and mRNA was prepared with the Dynabeads mRNA DIRECT Kit (Life Technologies), from HEK293 cells according to the manufacturer's instructions. For mapping of 2'Omethyl sites in rRNA 1 ᵰg of total RNA was used as starting material. To explore the existence of 2'Omethyl sites in mRNAs, poly(A)selected RNA (200ng) was used. In both protocols, the RNA was degraded under alkaline conditions in a sodium carbonate/bicarbonate buffer at pH 9.2 for 14 minutes and then put on ice. Samples were separated parallel to a low molecular weight marker ladder (10100nt) on a 15% denaturing polyacrylamide gel for 1 hour at 1400 V and 20 W. The gel was stained with GR Green nucleic acid stain (Excellgen) for 3 min and fragmented RNA ranging from 20 to 40 nt was cut out from the gel and extracted overnight in 0.4 M NaCl. The RNA was precipitated with 1 ᵰl of coprecipitant (GlycoBlue) in 75% ethanol at 20°C for 2 hours and then centrifuged at maximum speed for 10 min at 4°C. The RNA pellet was washed twice with 70% ethanol and airdried. The pellet was dissolved in water, the RNA was dephosphorylated with FastAP alkaline phosphatase (Thermo Scientific) at 37°C for 30 min and the enzyme was heatinactivated at 75°C for 10 min. Subsequently, the RNA was phosphorylated with polynucleotide kinase (Thermo Scientific) in the presence of 1 mM ATP at 37°C for one hour and then extracted with phenolchloroform and precipitated in 80% ethanol, washed with 70% ethanol twice and airdried. The pellet was dissolved in 8 ᵰl mix (4 ᵰl H 2 O, 1 ᵰl 10x truncated T4 RNA Ligase 2 buffer, 1 ᵰl 100 uM 3' rAppadapter (5' adenylated 3' adapter, 5'AppTGGAATTCTCG GGTGCCAAGGamino3'), 2 ᵰl 50% DMSO), denatured at 90°C for 30 seconds and chilled on ice. Next, RNasin Plus RNase inhibitor (Promega) and T4 RNA Ligase 2 truncated were added to a final concentration of 2 U/ᵰl and 30 U/ᵰl, respectively, and the reaction was incubated at 4°C for 20 hours over night. The next day, 1 ᵰl of RT primer (100 ᵰM; 5'GCCTTGGCAC CCAGAGAATTCCA3') was added (for quenching of remaining 3' adapter molecules, preventing adapter dimers ligation in the next step), the samples were heated at 90°C for 30 seconds, at 65°C for 5 minutes, then placed on ice. A 5'adapter ligation mix was then directly added to the sample (1.5 ᵰl 10 mM ATP, 1ᵰl 100 uM 5' RNA Adapter RA5 (Illumina TruSeq RNA sample prep kit), 1 ᵰl T4 RNA Ligase 1 (20 U/ᵰl), 0.5 ᵰl RNasin Plus RNase inhibitor (40 U/ᵰl) and reactions were incubated at 20°C for 1 h and 37°C for 30 minutes. The RNA was then directly reverse transcribed in a 30 ᵰl reaction by adding dNTPs to 0.5 mM, DTT to 5 mM, 1x SSIV buffer, RNAsin to 2 U/ᵰl and 1 ᵰl Superscript IV reverse transcriptase (Life Technologies). The sample was incubated at 50°C for 30 min and inactivated at 80°C for 10 min. 5 ᵰl of the resulting cDNA was then used in a pilot polymerase chain reaction (PCR) reaction. To this end, aliquots were taken from reactions at every second cycle between 12 and 22 cycles and analyzed on a 2.5 % agarose gel. The number of cycles causing a first visible amplification was chosen for a large scale PCR (10 ᵰl cDNA in a 100 ᵰl reaction). The PCR product was ethanol precipitated and run along a 20 bp marker on a 9% nondenaturing polyacrylamide gel in TBE for 1 hour at 250 V, 20 W. The gel was dismantled and stained for three minutes with GR Green. PCR products between 125 bp and 175 bp were cut out, the gel piece was mashed and DNA was eluted overnight into 400 ᵰl of H20. The supernatant was separated from the gel particles in a SpinX filter column (Costar), NaCl was added to 0.4 M, DNA was ethanol precipitated, the pellet washed in 75% ethanol and dissolved in 20 ᵰl H 2 O. Libraries were sequenced on an Illumina HiSeq2500 deep sequencer (GEO accession # for the data sets pending). Their summary can be found in Supplementary Table 4 .
Mapping of RiboMethseq reads
We obtained~50 million reads for each of the RiboMethseq samples. The adaptor was removed with Cutadapt (minimumlength 15, other parameters left with default values) (43) and reads were mapped with STAR (additional parameters: outFilterMultimapNmax 20 outFilterMismatchNoverLmax 0.05 scoreGenomicLengthLog2scale 0 outSAMattributes All) (44) to a human hg19 assembly versionbased transcriptome composed of rRNAs, snRNAs and snoRNAs as well as to lincRNAs, miscRNAs, and all unspliced protein coding genes (obtained from hg19 version of ENSEMBL, http://grch37.ensembl.org/index.html ) (41) , supplemented with a set of tRNAs (as decribed in section SnoRNA and target sets).
Calculation of a RiboMethseq score
RiboMethseq data was evaluated based on "score A", defined in a previous publication (2) and computed from the mean and standard deviation of the summed coverage of 5' and 3' ends at positions neighboring a position of interest. Finding that this score is very sensitive to the coverage and that it does not distinguish very well the true positives (Supplementary Figure 3C ), we explored other approaches for analyzing the data. In particular, we tested whether the *change* in cleavage frequency at adjacent positions is indicative of 2'Omethylation, as we expect very little read coverage at 2'OMe positions compared to their immediate neighborhood. Thus, for each target of interest such as the 18S rRNA, we calculated the log2 normalized (to a total library size of 10 6 reads) profile of cleavage positions from the 5' and 3' read ends (separately) and then computed the angle defined by the log2 coverage values at positions 1, 0, and +1 with respect to any position along the RNA (Supplementary Figure 3A ). An angle of 180° indicates that the three positions have the same cleavage frequencies, 0°indicates that the central position has very high coverage compared to the neighboring positions (and is therefore not protected from cleavage) and 360°indicates that the central position has very little coverage (and therefore it is protected from cleavage) compared to the neighboring positions. Thus, as a RiboMethseq score we took the average angle computed based on 5' and from 3' read ends, as both ends are determined by alkaline hydrolysis. Calculating the precision, accuracy, recall and precisionrecall curves, we found that this score yields a higher precision compared to the 'score A' (2) (Supplementary Figure 3B and C). For each individual experiment in predicting 2'OMe sites we used a score threshold of 290°, favoring slightly recall over precision. Detail statistics for experiments can be found in Supplementary Table 4 . Finally, we combined all RiboMethseq experiments and calculated the average score over 7 experiments using the following procedure. We collected putative 2'OMe sites from all experiments and retained those that had a score above the threshold in at least one experiment. For these, we calculated the average score across the 7 experiments. To determine a threshold for this average score and then determine the PR curve and Matthews correlation coefficient (Supplementary Figure 3D and E), we included among the positives not only the sites that we identified with RiboMethseq but also 19 additional sites that are known to undergo methylation, but that were not captured as positives from our experiments. This resulted in a set of 105 known interactions in the 18S and 28S rRNAs. We found the optimal threshold for the average angle score to be very close to the score for a single experiment, namely 295, giving a recall of 72.3% and precision 84.4% on rRNAs. This indicates that the known 2'Omethylation sites are captured with very high probability in all RiboMethseq experiments.
Validation of 2'Omethylation sites with RTLP
Similar to the classic primer extension assays (45) , the Reverse Transcription at Low deoxyribonucleoside triphosphate (dNTP) method (RTLP, (46) ) takes advantage of the observation that cDNA synthesis through a 2'OMe nucleotide is impaired when dNTPs are limiting. However, RTLP is less cumbersome and more sensitive than primer extension assays. The RTLP procedure includes a sitespecific primer extension by reverse transcriptase at a low dNTP concentration and a semiquantitative PCR amplification step, followed by agarose gel electrophoresis to obtain ratios of PCR signal intensities. To increase sensitivity and reproducibility, we implemented a realtime PCR (qPCR) step to facilitate the analysis of the signal intensities (primers shown in Supplementary Table 5 ).
RESULTS
Crosslinking and immunoprecipitation of core snoRNPs captures snoRNAtarget site chimeras
Although miRNAs and snoRNAs differ substantially in their mode of action, they share the function of guiding ribonucleoprotein complexes to target RNAs. Thus, by analogy with miRNAs (30) , we hypothesized that chimeric reads composed of snoRNAs and their targets should also be captured in CLIP experiments of core components of the snoRNP complex, the 15.5K, Nop58, Nop56 and fibrillarin proteins. Therefore, we analyzed the reads obtained in 6 photoreactive nucleosideenhanced (PAR)CLIP experiments that targeted one of these core proteins with a method similar to that previously employed by Grosswendt et al. (30) . We found that on average~10% of the reads that could not be mapped to the genome or transcriptome seem to be chimeric, composed of a snoRNA and a target part and that~5% have the target part longer than 15 nucleotides. Furthermore, in the vast majority of the chimeric reads (~80%) the snoRNA could be identified unambiguously. The statistics of the reads obtained in all of these experiments are shown in Supplementary Table 2 . To determine whether the snoRNAtarget associations that we inferred from chimeric reads were due to a bona fide interaction between the molecules, we randomized the snoRNA assigned to each target fragment in the chimeras and calculated the predicted energies of interaction of the real and randomized pairs of molecules with PLEXY (22) (see also Methods). As shown in Figure 2A , the interaction energy predicted for the snoRNAtarget chimeras was significantly lower compared to randomized sequence pairs, indicating that the chimeras reflected specific interactions of snoRNAs with their targets.
A model to identify highconfidence snoRNAtarget chimeras
Reasoning that features beyond the predicted energy of interaction between a snoRNA and a putative target site may also be informative in identifying true modification sites, we divided the interactions that were captured in chimeric reads into known (positives) and yetunknown (likely negatives) and compared the distributions of values of features that have been found to play a role in other small RNAguided interactions (47) . As shown in Figure 1A and D, the PLEXY score (22) of the putative snoRNAtarget interaction had the highest discrimination power. In addition, we found that snoRNAguided methylation sites seem to reside in structurally accessible (singlestranded) regions of rRNAs ( Figure 1B) and in an Arich nucleotide environment ( Figure 1C ). We then used the following features to train a generalized linear model (GLM) for the prediction of snoRNAtarget interactions:
1. Energy of interaction between the snoRNA and the target, calculated with the PLEXY software for snoRNA target prediction (22 We trained the model on chimeric reads involving the rRNA28S and then tested it on chimeric reads involving the rRNA18S. We found that the area under the ROC curve was~85% and the model could recall 70% of the known interaction sites with 65% precision (Figure 1E,F) . To construct a model for the comprehensive prediction of snoRNA target sites from chimeric reads, we used all known sites in the 28S and 18S rRNAs. At a score threshold of 0.15 we obtain good performance in predicting rRNA modification sites, with a Matthews correlation coefficient (MCC) of 0.19, a precision of 0.75 and recall value of 0.74 ( Figure 2BD ). Therefore, we used this threshold to analyze the genomewide data of putative snoRNA target sites that were supported by chimeric reads from at least 2 experiments. 
Chimeric reads reveal novel C/D box snoRNA target sites within structural RNAs
We applied the derived model to identify snoRNA interactions with structural RNAs, including beyond rRNAs, snoRNAs, tRNAs and the snoRNAs themselves. Among the 2'OMe sites in rRNAs that are presumably guided by C/D box snoRNAs, only one, at position G1383 in the 18S rRNA, is "orphan", meaning that its guide snoRNA is unknown. Our data indicates that this modification is guided by SNORD30. In addition, in spite of snoRNAs having been studied for a long time, the chimeric reads revealed 39 novel interactions, at 34 distinct methylation sites in rRNAs (16 in rRNA 18S, 21 in rRNA28S and 2 in rRNA5.8S). Eleven of these interactions involve snoRNAs that have been so far classified as "orphan" (Supplementary Table 6 ). As a specific example, we found that a recently uncovered orphan snoRNA with low but broad expression across tissues, snoID_0701 (family unknown) (Jorjani et al. submitted) , was represented among the chimeric reads from two experiments, having a low predicted energy of interaction (28.2 kcal/mol) with rRNA28S, and the predicted position of modification U2756. Similarly, another snoRNA of unknown family (snoID_372) was found in three experiments to interact with rRNA28S (predicted energy of interaction of 24.8 kcal/mol) being predicted to guide 2'Omethylation at position 4953.
SnRNAs are also known targets of snoRNAguided 2'Omethylation. Of the 9 such sites that are known, we were able to recover 4 with highconfidence and another 2 with less support, but still captured among chimeric reads. Additionally, we identified a novel interaction of SNORD23, a snoRNA that is currently considered orphan, with position 64 of the U6 snRNA (Supplementary Table 6 ).
Although tRNAs are known to undergo extensive modification including 2'Omethylation, to our knowledge no evidence has so far been provided for snoRNAguided modification of tRNAs in animals. In yeast, 2'Omethylation of riboses in tRNA nucleotides is catalyzed by the methyltransferase Trm7p (48) . Here we identified 4 highconfidence interactions of snoRNAs with tRNAs ( Supplementary Table  6 ). Among these, the interaction of the orphan SNORD124 with tRNA SerTCY has a relatively low interaction energy of 20.0 kcal/mol and is supported by 3 experiments.
Additionally, we identified 3 interactions of snoRNAs with other snoRNAs. We found an interaction of SNORD5 with SNORD56, of SNORD50 with SNORD57 and of SNORD34 with SNORD38A. One snoRNA, SNORD4B, was found in a chimeric read as both guide and target fragment. Whether all these interactions do indeed lead to 2'Omethylation or they serve different function remains to be determined (more on this issue below). 
Chimeras capture novel interaction sites outside of typical snoRNA targets
Apart from known and novel snoRNA interactions with structural RNAs the chimeric read data revealed 668 high confidence interactions that did not reside in the typical snoRNA targets, of which 61 (9.1%) involved orphan snoRNAs (Figure 3 ). The relative frequencies of 2'OMe at individual nucleotides were similar to those from known modification sites, where adenines are most frequently targeted ( Figure 3A) . Based on the ENSEMBL genome annotation we could annotate 433 of the 668 interaction sites, most of which were located in proteincoding genes (303 sites) followed by repeats (45), pseudogenes (18) and lincRNA (12) ( Figure 3D ). The relative frequencies of targeting different types of genes did not differ substantially between orphan and canonical snoRNAs.
Two of the identified interactions with lincRNAs involved orphan snoRNAs: SNORD73A was found to interact with LINC00954 and snoID_0436 with RP11554F20.1. The others involved snoRNAs that are known to guide modification of canonical sites in rRNA Supplementary Table 6 .
Most of the 303 mRNAlocated sites were located in introns (66%), 26% were located in exons and 8% in regions that undergo alternative splicing (annotated as both intronic and exonic, Figure 3E ). 35 (45%) of the 78 exonic target sites were located in CDS and 28 (36%) in 3' UTRs ( Figure 3F ). These proportion correspond approximately to the total length of different types of regions in the genome, indicating a lack of positional bias of snoRNA binding to mRNAs.
To gain additional insight into the processes that may be regulated by snoRNA binding to mRNAs we analyzed the membership of the mRNAs that were captured in chimeric reads in KEGG pathways as well as their disease associations with the WEBbased GEne SeT AnaLysis Toolkit ( http://bioinfo.vanderbilt.edu/webgestalt/ ) (49) . We found that the two most enriched KEGG pathways were glioma and axon guidance ( Supplementary Table 7 ). Correspondingly, the strongest associations were with neurodegenerative diseases and psychiatric disorders including schizophrenia (Supplementary Table 8 ). For example, SNORD62 appears to target huntingtin (HTT). The consequence of this interaction is however unclear.
SNORD14, SNORD17 and SNORD26 yielded most chimeras with mRNAs ( Figure 3B and C). This is not due to their relative abundance, because these snoRNAs are not among the highest expressed. Rather, SNORD14 and SNORD17 were previously reported to have functions beyond 2'Omethylation of ribose. In particular, SNORD14C was suggested to act as a chaperone in prerRNA processing (50) as well as to guide 2'Omethylation at position 462 of rRNA18S. SNORD17 is unusually long for a C/Dbox snoRNA (51) and was also identified as one of the small noncoding RNAs that associates with telomeres (52) . A role of snoRNAs in alternative processes such as alternative splicing has been suggested before (53) and recently, the interaction of SNORD88 (HBII180C) with FGFR3 transcripts has been found to influence their splicing (54) . Our data contained a chimeric read of SNORD88 with an FGFR3 intron, an interaction predicted to have relatively low energy (14.2 kcal/mol). However, this interaction is observed in only one experiment and we did not consider it as high confidence.
Identification of snoRNAguided 2'OMe sites with RiboMethseq
To further characterize the consequence of the snoRNAtarget interactions identified from CLIP data, we applied RiboMethseq, a method that was recently developed to accurately map 2'OMe sites in rRNAs in highthroughput (2) . We carried out seven experiments, six using total RNA, which contains both rRNAs the canonical snoRNA targets as well as other RNA species, and one using poly(A)+ RNAs, which is thereby strongly enriched in mRNAs. Two of the total RNA samples were prepared from total cell lysate, two from the nuclear fraction and two from the cytoplasmic fraction. We also developed an improved method for identifying 2'OMe sites from RiboMethseq data (see Materials and Methods section), and thereby identified 172 highconfidence 2'OMe sites, 92 of which novel. 55 (60%) of the novel sites were located in canonical snoRNA targets snRNA, rRNAs and tRNAs, and only 29 in mRNAs.
From the 753 highconfidence snoRNA target sites identified with CLIP we found that 140, almost exclusively located in rRNAs, are indeed followed by 2'Oribose methylation detectable with RiboMethseq. These interactions involved 93 distinct target sites, as multiple snoRNAs appear able to interact with the same target site. 117 interactions, at 78 2'OMe sites, were already known from previous studies and included 29 out of the 45 known 2'OMe sites in rRNA 18S (65%), 46 out of 60 2'OMe sites in rRNA 28S (76%), the known site at position 75 in rRNA 5.8S and 2 sites in the U6 snRNA. Figure 4 shows the location of previously known 2'Omethylation sites in the 18S and 28S rRNAs, as well as the corresponding chimeric read and RiboMethseq evidence that we obtained here for these rRNAs.
There are only few novel snoRNAtarget interaction sites identified with high confidence from chimeric reads that seem to direct 2'Omethylation. For example, SNORD2 appears to guide 2'Omethylation at position G2435 in the 28S rRNA. Almost all others may be due to homology with known 2'Omethylation sites: they were located in different snRNAs isoforms, 2 were in snoRNAs (including an interaction of SNORD4B with itself) and one was in the MTRNR2L6 (Mitochondrially Encoded 16S RNA like 6 protein) transcript, which is similar to the mitochondrially encoded 16S RNA. Thus, the RiboMethseq data does not support a role of snoRNAs in guiding 2'Omethylation at sites with which they interact outside of the structural RNAs. 
Identification of snoRNA guides for novel 2'OMe sites obtained with RiboMethseq
As mentioned above, 92 of the RiboMethseqderived sites of 2'Omethylation were novel and also did not correspond to highconfidence sites inferred from chimeric reads. However, not all 2'OMe sites are captured reproducibly in chimeric reads and thus, we took a more inclusive approach in assigning snoRNA guides to RiboMethseqderived 2'OMe sites. First, we relaxed the constraint that sites should be captured with high confidence in chimeric reads, taking into consideration even single chimeric reads as long as the predicted energy of interaction between the snoRNA and the putative target site was not higher than 6 kcal/mol. With this approach we were able to assign guides to another 5 RiboMethseqsupported 2'OMe sites in rRNAs: 2'OMe of G2468 in the 28S rRNA seems to be guided by two orphan snoRNAs from the snoU13 family (see Jorjani et al. submitted ), that of G3606 by SNORD12, of G3771 by SNORD21 and of G4996 by SNORD96B, whereas 2'Oribose methylation of C174 in the 18S rRNA is guided by SNORD45C.
Many "orphan" snoRNAs redundantly target known sites of 2'Oribose methylation
One of the main open questions in the snoRNA field concerns the targets and functions of the many orphan snoRNAs. At this point, there are 330 orphan snoRNAs that can be grouped into 219 families (Jorjani et al. submitted) . Here we found that 66 of these orphan snoRNAs still seem to have canonical targets, acting almost exclusively on known modification sites, which have been previously assigned to other snoRNAs. Among these snoRNAs are:
• SNORD118 guiding modification of G1612 of rRNA28S (supported by chimeric reads from 6 experiments), as does SNORD80 • snoRNAs of the SNORD115 family appear able to guide modification of A4560 of rRNA28S, previously assigned to SNORD119. One of these interactions has a very low predicted energy (20 kcal/mol) and is supported by chimeric reads from 5 experiments • the recently predicted snoRNA snoID_0719 (Jorjani et al. submitted) guides the modification of C3680 of rRNA28S, previously attributed to SNORD88
• snoRNAs of the SNORD114 family appear to guide methylation of U4590 of rRNA28S, previously assigned to SNORD72 All the sites are summarized in Supplementary Table 6 .
Assignment of highconfidence 2'OMe sites to snoRNAs with PLEXY
Finally, we considered the possibility that no chimeric reads were captured for some of the novel high confidence 2'OMe sites identified with RiboMethseq. To predict snoRNA guides for these sites, we extracted sequences of 15 nucleotides around the 92 2'OMe RiboMethseqbased identified sites and carried out snoRNA target predictions with PLEXY, discarding the two sites that were located in PATCH chromosomes. With this procedure we were able to assign snoRNA guides to 54 out of 90 novel methylation sites, leaving 40% of the novel RiboMethseq sites without an assigned snoRNA. To many 2'OMe site we could assign more than one snoRNA including small noncoding RNAs classified as SNORDlikesnoRNA (Jorjani et al. submitted) . This predictions are summarized in Supplementary Table 9 . Motif analysis with MEME (55) of the sequences around 2'OMe sites that were still left without a snoRNA guide did not reveal any significant motif, and thus it does not appear that they can be assigned to a small number of regulators. Analysis of these regions surrounding these sites with RNAfold (56) did not reveal any significant structure that could explain the capture of these sites in RiboMethseq although methylated position tended to be unpaired in comparison to same sequences shuffled (Supplementary Figure 4A and B).
Evidence of 2'Omethylation of CLIPbased identified sites in RiMseq data
Lastly, we wondered whether some of the sites that we captured in chimeric reads were false negatives of the RiboMethseq method. We therefore asked whether evidence for their 2'Omethylation can be found in the RiMseq data that we obtained in a previous study (Jorjani et al. submitted). Starting from highconfidence RiMseqdefined sites of 2'Omethylation we were able to find chimeric read support for chr12:G49050514 (hg19 version of the human assembly from the University of California Santa Cruz, genome.cse.ucsc.edu), which is located in the SNORA2A snoRNA and whose modification seems to be guided by SNORD118, and chr12:G6690685, located in SCARNA11, whose modification could be guided by SNORD6. With this approach we also confirmed two novel RiboMethseq and CLIPsupported 2'Omethylation sites in the 28S rRNA: G3606, whose modification is guided by SNORD12 and G3771, bound by SNORD21. All the results can be found in Supplementary Table 6 .
Lowthroughput experimental validation of 2'OMe sites
For additional validation of novel 2'OMe sites that we identified as described above, we applied the recently published Reverse Transcription at Low deoxyribonucleoside triphosphate (dNTP) concentrations, which we then followed with qPCR, to improve quantification (RTLP (46) ). We first tested RTLP on a known modification site, position A1031 in the human rRNA18S, and obtained a positive result ( Supplementary Figure 5A and B). We also performed RTLP on the site U1991 in 28S rRNA which has no known nucleotide modification (Supplementary Figure 5C ). As expected, we obtained a negative result. Next, we applied the method to position G2435 in rRNA28S, which we identified as a novel 2'OMe site based on chimeric reads and RiboMethseq. As shown in Figure 5A and B we found that the unanchored MeURT primer yielded significantly less cDNA and hence PCR product than the anchored MeART primer at low dNTP concentrations. Although the effect is less pronounced compared to the site A1031 in rRNA18S, there is a significant difference in the PCR products obtained with the two primers at low dNTP concentrations, whereas no such difference can be observed at high dNTP concentrations. This result indicates that sites that emerged from both CLIP as well as RiboMethseq are indeed subject to 2'Oribose methylation.
Limited evidence for noncanonical binding of C/Dbox snoRNAs
Finally, to allow for the possibility that some of the chimeric reads captured noncanonical snoRNAtarget interactions that involve snoRNA regions outside of antisense boxes, which will not be identified with PLEXY, we used a general RNARNA interaction model implemented in the RNAduplex tool (57) to predict the energy of interaction between the snoRNA and target fragments of chimeric reads (Supplementary Figure 6) . Interestingly, two snoRNAs for which we predicted the highest number of noncanonical interactions, SNORD14 and SNORD17, were previously reported to facilitate rRNA processing, participating in the cleavage of the 5' external transcribed spacer rather than in 2'Omethylation (50) . For SNORD17 the chimeric reads indeed captured a specific snoRNA subsequence that was not one of the antisense boxes but rather the sequence AGCCTCAGTTCCTG located at positions 58 to 71 of the snoRNA (between the D' and C' boxes). This sequence was also predicted to basepair stably with target regions (Supplementary Figure 6C and 7A and  B) . For other snoRNAs the predicted pattern of basepairing with the target fragments from chimeric reads was diffuse along the snoRNA (eg. SupplementaryFigure 6D). Whether C/Dbox snoRNAs carry out functions beyond 2'Omethylation of ribose or the snoRNAs can be captured in transient interactions that lack functional relevance with molecules such as mRNAs will require additional work and should be addressed by future studies.
DISCUSSION
Highthroughput sequencing technologies coupled with specific treatments and sample preparation have enabled the characterization of transcriptomes at ever increasing depth and resolution. This lead to the realization that the noncoding transcriptome is as large as the proteincoding fraction (58) and to the discovery of new members of all classes of RNAs, including miRNAs and snoRNA (59, 60) . The large number of novel molecular species that were discovered increased the need for functional characterization methods, ideally in highthroughput. The aim of our study was to provide such methods for a specific class of noncoding RNAs, the C/Dbox snoRNAs. A recent study to which we contributed expanded the catalog of human snoRNAs by 41 CDbox new molecules (Jorjani et al. submitted) and tried to identified snoRNA targets for the 118 C/D box snoRNAs that were up to that point considered "orphan".
Here we have combined two highthroughput approaches, the first of which aims to identify direct interactions between snoRNAs and targets and the other to map sites of 2'Omethylation genomewide. Because many small RNAs function as guides for ribonucleoprotein complexes, the mapping of RNARNA interactions has initially been done indirectly, by crosslinking and immunoprecipitation of proteins from these complexes (28, 29, 61) . Due to the relatively weak sequence complementarity constraints and because the small RNA guides typically form families of sequencerelated molecules, inferring the small RNA that guided the interaction with each presumed target site determined by CLIP has not been trivial. This led to efforts to capture RNARNA interactions directly, which has been accomplished initially through the addition of an RNARNA ligation step in CLIP (25, 26) . Very recently, through careful analysis of CLIP data, Grosswendt and colleagues found that a specific ligation is not necessary, because endogenous ligases already generate miRNAtarget site chimeras that can be found in CLIP samples (30) . Whether this is also the case for CLIP carried out with the core snoRNP proteins has not been investigated. Developing a computational data analysis method for the identification of C/D box snoRNAtarget hybrids from Nop56/Nop58/FibrillarinCLIP data was the first aim of our study. Due to the relatively short length of the snoRNA and target fragments that are captured with CLIP, the relative rarity of chimeric sequences, in the range of less than a percent of the reads (30) and the large proportion of "background" sequences in CLIP (29) , a careful analysis that considers the specific basepairing pattern of snoRNAs with targets is necessary. Using the sites in rRNA28S we have trained a model that shows very good sensitivity and specificity in predicting the 2'OMe sites in the rRNA18S. We applied this model to all chimeric sequences from 7 CLIP experiments and identified 753 highconfidence snoRNAinteraction sites including 39 novel interactions in rRNAs.
To investigate the consequences of the identified interactions, we have adapted a highthroughput method, RiboMethseq, that was previously applied to the identification of 2'OMe sites in yeast rRNAs (2) and we have developed an improved method for the computational analysis of these data. We found that the approach identifies 72% of the known 2'OMe sites in rRNAs with a precision of 85%. Interestingly, we found that many of the snoRNAs that were considered "orphan" seem to guide interactions with sites that have already been assigned to other snoRNAs. That is, it appears that there is substantial redundancy of snoRNAs in guiding specific modifications, whose importance for cellular function deserves further investigation. Combining the CLIP with RiboMethseq we have validated with high confidence 104 of the 190 known snoRNAguided interactions with structural RNAs as well as their consequence, namely the 2'Omethylation of the target. Only 14 of the known 2'OMe sites could not be validated ( Supplementary Table 10 ). These results indicate that our approach is very well suited for the characterization of C/D box snoRNAtarget interactions in highthroughput. Additional validation of a novel rRNA modification site with an independent, low throughput method ( (46) ) indicates that the CLIPRiboMethseq approach is reliable. Although in species such as yeast or human these interactions have been extensively studied for a relatively long time and much is already known, the approach should be suitable for other species as well.
Our analysis indicates also that neither of the methods is fully comprehensive in its coverage. Although this could be due to some extent to the cell typespecificity of expression or intermolecular interactions, it is the case that guide RNAtarget chimera are captured with low efficiency with the approaches that are currently available (26, 30) and in this aspect, there is room for further improvement. In RiboMethseq, a low expression of the 2'Omethylated RNAs could hinder their identification. This could be a problem for the identification of modification sites in targets that are expressed in a tissuespecific manner, in mRNAs or lincRNAs, whose abundance per cell is much lower compared to the rRNAs. This could be a reason for the lack of experimental validation of 2'Omethylation of mRNA target sites that emerged from chimeric reads. The data that we obtained with the RTLP approach also suggests that at least some of the novel sites of snoRNAtarget interaction are not methylated with 100% efficiency, indicating that an increased sensitivity of detection of 2'OMe sites may confirm the role of newly discovered interactions in 2'Oribose methylation. Alternatively, not all snoRNAtarget interactions lead to 2'Omethylation. Indeed, an ancestral function of snoRNAs in rRNA processing that is still preserved in the U3 snoRNA has been proposed (20) . Which snoRNAs have retained an ancestral function or have acquired functions beyond 2'Omethylation remains to be determined. RiboMethseq also revealed a few highconfidence sites for which we did not find any corresponding chimeric reads. Although this could be due to the limited coverage of snoRNAtarget interactions by chimeric reads, they could represent sites that are resistant to alkaline hydrolysis for reasons other than 2'OMe. Supporting this latter hypothesis, these sites are generally located in rRNAs or snRNAs, molecules that are extensively modified and highly structured. Moreover, in contrast to rRNAknown modification sites, which do not exhibit any nucleotide bias, the new sites recovered by RiboMethseq show a strong Gbias (Supplementary Figure 3F ). This could indicate that these modifications are introduced by specific enzymes such as the transfer RNA methyltransferase 7 protein (62) .
Our approach would be particularly interesting to apply to study the role of C/D box snoRNAs in development or across cell types. Indeed, in updating the catalog of human snoRNAs, we have found that a substantial proportion of snoRNAs has a strong specificity for neuronal cells, and that there is a snoRNA expression signature of cancers (Jorjani et al. submitted) . Interestingly, although we performed our analysis in HEK cells, analysis of disease associations of the mRNAs that were captured in chimeric reads revealed that most targeted diseases are neurological disorders. The significance of snoRNA expression changes can be studied with the techniques we established here. 
